PFE
Pfizer Inc
30.70$
+0.5%
vs. previous close
Closing price · As of: Nov 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 19.3% | 19.7% | 23.3% | 21.4% | 22.0% | 19.7% | 20.4% | 37.9% | 33.9% | 41.9% | 28.1% | 25.7% | |
| 80.7% | 80.3% | 76.7% | 78.6% | 78.0% | 80.3% | 79.6% | 62.1% | 66.1% | 58.1% | 71.9% | 74.3% | |
| 16.9% | 15.7% | 14.9% | 14.6% | 19.0% | 20.5% | 22.6% | 17.0% | 11.3% | 17.9% | 17.0% | 16.7% | |
| 22.2% | 24.0% | 22.0% | 22.2% | 28.8% | 29.5% | 23.6% | 13.2% | 10.8% | 18.6% | 18.0% | 21.8% | |
| 53.5% | 53.7% | 50.7% | 51.8% | 61.5% | 62.4% | 58.4% | 37.2% | 28.4% | 50.7% | 48.5% | 46.5% | |
| 27.2% | 26.6% | 26.0% | 26.8% | 16.5% | 17.9% | 21.2% | 24.9% | 37.7% | 7.4% | 23.5% | 27.8% | |
| 2.7% | 2.5% | 2.2% | 2.4% | 3.2% | 3.8% | 3.5% | 1.6% | 1.2% | 3.7% | 4.9% | 4.3% | |
| 24.7% | 18.4% | 15.8% | 23.4% | 8.8% | 27.7% | 16.9% | 29.9% | 34.3% | 1.8% | 12.6% | 12.0% | |
| 6.3% | 4.1% | 2.1% | -17.2% | -0.7% | 1.4% | 0.9% | 2.3% | 3.3% | -1.9% | 0.0% | -0.4% | |
| 18.4% | 14.2% | 13.7% | 40.6% | 27.3% | 39.2% | 22.0% | 27.0% | 31.0% | 3.6% | 12.6% | 12.4% | |
| 38.6% | 31.4% | 29.0% | 37.8% | 27.1% | 45.6% | 31.8% | 37.9% | 40.6% | 16.0% | 28.5% | 26.8% |
Data as of: November 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.